A citation-based method for searching scientific literature

B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
Times Cited: 53







List of co-cited articles
210 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
37

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
22

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
80
20

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
20


Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
16

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
34
26

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
309
15

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015
109
13


Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
13

Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
48
12


Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
76
11

Functional assays for analysis of variants of uncertain significance in BRCA2.
Lucia Guidugli, Aura Carreira, Sandrine M Caputo, Asa Ehlen, Alvaro Galli, Alvaro N A Monteiro, Susan L Neuhausen, Thomas V O Hansen, Fergus J Couch, Maaike P G Vreeswijk. Hum Mutat 2014
69
9

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Noralane M Lindor, Lucia Guidugli, Xianshu Wang, Maxime P Vallée, Alvaro N A Monteiro, Sean Tavtigian, David E Goldgar, Fergus J Couch. Hum Mutat 2012
139
9

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
70
9

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
115
9

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
223
9


Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
28
17

Accurate classification of BRCA1 variants with saturation genome editing.
Gregory M Findlay, Riza M Daza, Beth Martin, Melissa D Zhang, Anh P Leith, Molly Gasperini, Joseph D Janizek, Xingfan Huang, Lea M Starita, Jay Shendure. Nature 2018
218
9

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
181
7

A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.
Bryony A Thompson, David E Goldgar, Carol Paterson, Mark Clendenning, Rhiannon Walters, Sven Arnold, Michael T Parsons, Walsh Michael D, Steven Gallinger, Robert W Haile,[...]. Hum Mutat 2013
63
7

A full-likelihood method for the evaluation of causality of sequence variants from family data.
Deborah Thompson, Douglas F Easton, David E Goldgar. Am J Hum Genet 2003
87
7

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
665
7

A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
Courtney L Scherr, Noralane M Lindor, Teri L Malo, Fergus J Couch, Susan T Vadaparampil. Genet Med 2015
18
22

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
12

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
7

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
Jae Yeon Cheon, Jessica Mozersky, Robert Cook-Deegan. Genome Med 2014
54
7

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
185
7

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, Michael F Walsh, Vijai Joseph, Zsofia K Stadler, Katherine L Nathanson, Judy E Garber, Fergus J Couch, Kenneth Offit,[...]. J Clin Oncol 2016
97
7

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
7

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
7

The impact of variant classification on the clinical management of hereditary cancer syndromes.
Scott A Turner, Smita K Rao, R Hayes Morgan, Cindy L Vnencak-Jones, Georgia L Wiesner. Genet Med 2019
15
26

Family-Specific Variants and the Limits of Human Genetics.
Brian H Shirts, Colin C Pritchard, Tom Walsh. Trends Mol Med 2016
14
28

Physician interpretation of variants of uncertain significance.
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
25
16

ClinVar: public archive of relationships among sequence variation and human phenotype.
Melissa J Landrum, Jennifer M Lee, George R Riley, Wonhee Jang, Wendy S Rubinstein, Deanna M Church, Donna R Maglott. Nucleic Acids Res 2014
7

Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
Sarah Macklin, Nisha Durand, Paldeep Atwal, Stephanie Hines. Genet Med 2018
38
10

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
7

BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Noralane M Lindor, David E Goldgar, Sean V Tavtigian, Sharon E Plon, Fergus J Couch. Oncologist 2013
57
5

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.
C Sue Richards, Sherri Bale, Daniel B Bellissimo, Soma Das, Wayne W Grody, Madhuri R Hegde, Elaine Lyon, Brian E Ward. Genet Med 2008
517
5

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
David E Goldgar, Douglas F Easton, Amie M Deffenbaugh, Alvaro N A Monteiro, Sean V Tavtigian, Fergus J Couch. Am J Hum Genet 2004
274
5

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.
Amanda B Spurdle, Phillip J Whiley, Bryony Thompson, Bingjian Feng, Sue Healey, Melissa A Brown, Christopher Pettigrew, Christi J Van Asperen, Margreet G E M Ausems, Anna A Kattentidt-Mouravieva,[...]. J Med Genet 2012
66
5

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
5

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
5

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
208
5

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
Melissa K Frey, Sarah H Kim, Rebecca Yee Bassett, Jessica Martineau, Emily Dalton, Jing-Yi Chern, Stephanie V Blank. Gynecol Oncol 2015
26
11




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.